companydata.dkINPROTHER ApS
CVR: 33968426
Growing 48% p.a.Small companyWell-established (14 yrs)Loss-making
Secondary names: Hervolution Therapeutics ApS
Active
Overview
Company type
APS
Anpartsselskab
Founded
24.10.2011
Details
Employees
2 employees
1 FTE
(2018)
Capital
229.155,58 kr.
Contact
Advertising protectedEmail
Website
Purpose
Selskabets formål er at udvikle immunterapier mod kræft, aldring og neurodegenerative sygdomme som ALS, MS og Alzheimers samt enhver anden virksomhed, som bestyrelsen anser for at være forbundet hermed.
Location
Financials
| Year | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | -2.6 mio. | -8.6 mio. | 116.8 mio. | 75.9 mio. | 10 | |
History
Ownership
Owners
BIOSTRAT BIOTECH CONSULTING ApS
CVR: 30814622
5-9,99%
PETER HOLST CONSULTING ApS
CVR: 33965567
33,33-49,99%
EIC Fund
20-24,99%
INPROTHER ApS
CVR: 33968426
Management
Directors
John Robert M Coleman(ADM. DIR.)
Board
John Robert M Coleman(FORMAND)
Christian Olivier Thirion(BESTYRELSESMEDLEM)
Michael Sven Rohmann(BESTYRELSESMEDLEM)
Peter Johannes Holst(BESTYRELSESMEDLEM)
Production units (1)
INPROTHER ApS
P-no: 1017213047
Nordre Fasanvej 215, 2000, Frederiksberg
Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
2 employees
Similar companies
Companies in the same industry and area